Piramal Pharma Ltd. Financials: Quarterly Results
Revenue
2109.32
Cr.
PAT
-114.01
Cr.
EBITDA
21.45
Cr.
Piramal Pharma Ltd. Q2FY26 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 2043.72 | 1933.71 | 2754.07 | 2204.22 | 2241.75 |
| Total Income From Operations (Cr.) | 2043.72 | 1933.71 | 2754.07 | 2204.22 | 2241.75 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 21.45 | -32.18 | 360.26 | 153.06 | 210.50 |
| P/L Before Exceptional Items & Tax (Cr.) | -60.97 | -118.33 | 256.58 | 49.75 | 102.86 |
| P/L After Tax from Ordinary Activities (Cr.) | -114.01 | -100.27 | 137.28 | -13.37 | 5.33 |
| Net Profit/Loss For the Period (Cr.) | -114.01 | -100.27 | 137.28 | -13.37 | 5.33 |
| Basic EPS | -0.75 | -0.62 | 1.16 | 0.03 | 0.17 |
FAQs
Piramal Pharma Ltd. announced its quarterly results for Q2 FY2026 on November 6, 2025.
In Q2 FY2026, Piramal Pharma Ltd. are as follows:
Revenue: ₹2109.32 crore
Net Profit: ₹-114.01 crore.
For Q2 FY2026, Piramal Pharma Ltd. posted ₹2109.32 crore in revenue and ₹-114.01 crore in net profit.
Past quarterly results for Piramal Pharma Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.